NSGP 210 Case Studies in Pathophysiology – Concept map notes
| System: Condition |
| Basic Concept
|
| Pathophysiology |
| Risk Factors
|
| Etiology
|
| Pathophysiology (include different types here)
|
| clinical presentation (S&S)
* * * |
| Diagnostic Test/Procedures |
| Treatment
|
| Complications
|
This link provides an additional resource for your learning. Here you will find information on mnemonics, study information, test help, and practice questions. Access to this site is free of charge.
That one is an example of what someone did for my friend. Do not copy and paste it on my paper because I will know.
| System: Electrolyte Imbalance Condition: Hypo/Hypercalcemia Normal Levels: 8.6 to 10.3 mg/dL | |
| Basic Concept
· Calcium is an important electrolyte in the body. · The storage of the calcium takes place in the bones · Amount of calcium in the blood is tightly regulated · The level of calcium is controlled by Calcitonin and parathyroid hormone. · Calcium ions play an important role in regulation muscle contraction, enzyme activity, and blood coagulation. |
|
| Pathophysiology
· Calcium ions are critical to the signaling when controlling a variety of cellular processes. · Calcium exists as a free cation, in bound state, and complexed with other ions. · Calcium signaling pathway indicates the role of the mineral in regulating the enzymes and proteins. · Calcium function as a signal transducer through the activation of ion channels. |
|
| Risk Factors
Hpyo < 8.8 mg/dL · Vitamin D deficiency · Magnesium deficiency · Chronic and acute renal failure · Parathyroid problems · Certain medications |
Hyper > 10.5 mg/dL · Hyperparathyroidism · Some of forms of cancers including cancer of the lung and breast · Hereditary factors \ · Severe dehydration · Vitamin D over-supplementation |
| Etiology
Hypo < 8.8 mg/dL · Hypoalbuminemia · Hyperphosphatemia · Medication effects · Vitamin D deficiency |
Hyper > 10.5 mg/dL · Overactive parathyroid glands · 20-30% cancer patients develop hypercalcemia. · Elevated levels of Vitamin D. |
| Pathophysiology (Different Types)
· Hypocalcemia develops when the ECF falls below the recommended range · Hypercalcemia develops when there is a surge or rather an increase in the ECF calcium levels. · Changes in the calcium levels in the body results in an change in the total calcium in the extracellular matrix.
|
|
| Clinical Presentation
Hypercalcemia · CNS effects such as coma, confusion, lethargy · Renal effects such as polyuria, kidney stones, and renal failure · Gastrointestinal effects; constipation, anorexia, pancreatitis. Hypocalcemia · Neuromuscular symptoms; dysphagia, muscle cramps, numbness · Neurologic symptoms; irritability, fatigue, seizures · Dermatologic manifestation; coarse hair, brittle nails, cataracts, poor dentition. |
|
| Diagnostic Tests
· Hyperglycemia: Diagnosed using blood tests · Hypoglycemia: Basic Blood Tests/Metabolic Panel |
|
| Treatment
Hypo · Vitamin D supplementation · Magnesium and Calcium supplementation · Change in the diet |
Hyper · Reduction in dietary intake of calcium and Vitamin D · Giving the patient Bisphosphonates · Treating using denosumab (Xgeva) |
| Complications
Hypercalcemia · Osteoporosis · Kidney Stones · Kidney failure · Nervous system problems · Arrhythmia
|
Hypocalcemia · Fractures · Disability · Chronic Muscle Pain · Dental Problems · Seizures
|
References
Capriotti, T., & Frizzell, J. P. (2016). Human pathophysiology: Introductory concepts and clinical perspectives.
Assigned class notes for this week due 5/31 @ 2359
Please submit 6 notes for the grade. The grade will be determined by the percentage completed. The other topics will be on the midterm exam